{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:57:57Z","timestamp":1778158677807,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s12325-012-0042-8","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T11:14:47Z","timestamp":1345202087000},"page":"655-663","source":"Crossref","is-referenced-by-count":41,"title":["Ulipristal Acetate: a Novel Option for the Medical Management of Symptomatic Uterine Fibroids"],"prefix":"10.1007","volume":"29","author":[{"given":"Vikram S.","family":"Talaulikar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac T.","family":"Manyonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"key":"42_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.AOG.0000154161.03418.e3","volume":"105","author":"L.A. Wise","year":"2005","unstructured":"Wise LA, Palmer JR, Stewart EA, Rosenberg L. Agespecific incidence rates for self-reported uterine leiomyomata in the Black Women\u2019s Health Study. Obstet Gynecol. 2005;105:563\u2013568.","journal-title":"Obstet Gynecol"},{"key":"42_CR2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1471-0528.2006.00885.x","volume":"113","author":"W.J. Walker","year":"2006","unstructured":"Walker WJ, Barton-Smith P. Long-term followup of uterine artery embolisation \u2014 an effective alternative in the treatment of fibroids. Br J Obstet Gynaecol. 2006;113:464\u2013468.","journal-title":"Br J Obstet Gynaecol"},{"key":"42_CR3","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/humrep\/12.9.1927","volume":"12","author":"P. Seinera","year":"1997","unstructured":"Seinera P, Arisio R, Decko A, Farina C, Crana F. Laparoscopic myomectomy: indications, surgical technique and complications. Human Reprod. 1997;12:1927\u20131930.","journal-title":"Human Reprod"},{"key":"42_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0015-0282(99)00061-8","volume":"71","author":"A. Davies","year":"1999","unstructured":"Davies A, Hart R, Magos AL. The excision of uterine fibroids by vaginal myomectomy: a prospective study. Fertil Steril. 1999;71:961\u2013964.","journal-title":"Fertil Steril"},{"key":"42_CR5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajog.2004.03.037","volume":"191","author":"J.B. Spies","year":"2004","unstructured":"Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multi-centre study. Am J Obstet Gynecol. 2004;191:22\u201331.","journal-title":"Am J Obstet Gynecol"},{"key":"42_CR6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2214\/ajr.183.6.01831713","volume":"183","author":"J. Hindley","year":"2004","unstructured":"Hindley J, Gedroyc WMW, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004;183:1713\u20131719.","journal-title":"AJR Am J Roentgenol"},{"key":"42_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1471-0528.2004.00414.x","volume":"112","author":"T.T. Carpenter","year":"2005","unstructured":"Carpenter TT, Walker WJ. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG. 2005;112:321\u2013325.","journal-title":"BJOG"},{"key":"42_CR8","volume-title":"Guide to the methods of technology appraisal (ref. N0515)","author":"National Institute for Clinical Excellence.","year":"2004","unstructured":"National Institute for Clinical Excellence. Guide to the methods of technology appraisal (ref. N0515). London: National Institute for Clinical Excellence, April 2004."},{"key":"42_CR9","first-page":"20","volume":"55","author":"E.A. Wilson","year":"1980","unstructured":"Wilson EA, Yang F, Rees ED. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissue. Obstet Gynecol. 1980;55:20\u201324.","journal-title":"Obstet Gynecol"},{"key":"42_CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00016348509155136","volume":"64","author":"T. Tamaya","year":"1985","unstructured":"Tamaya T, Fujimoto J, Okada H. Comparison of cellular levels of steroid receptors in uterine leiomyomas and myometrium. Acta Gynaecol Scand. 1985;64:307\u2013309.","journal-title":"Acta Gynaecol Scand"},{"key":"42_CR11","unstructured":"Talaulikar VS, Belli A, Manyonda I. GnRH agonists: do they have a place in the modern management of fibroid disease? J Obstet Gynecol India. In Press."},{"key":"42_CR12","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/humrep\/16.8.1726","volume":"16","author":"J.B. Dubuisson","year":"2001","unstructured":"Dubuisson JB, Fauconnier A, Fourchotte V, Babaki-Fard K, Coste J, Chapron C. Laparoscopic myomectomy: predicting the risk of conversion to an open procedure. Human Reprod. 2001;16:1726\u20131731.","journal-title":"Human Reprod"},{"key":"42_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/humrep\/14.1.44","volume":"14","author":"S. Campo","year":"1999","unstructured":"Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophinreleasing hormone analogues. Human Reprod. 1999;14:44\u201348","journal-title":"Human Reprod"},{"key":"42_CR14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/humrep\/13.4.873","volume":"13","author":"P. Vercellini","year":"1998","unstructured":"Vercellini P, Maddalena S, Giorgi OD, Aimi G, Crosignani PG. Abdominal myomectomy for infertility: a comprehensive review. Human Reprod. 1998;13:873\u2013879.","journal-title":"Human Reprod"},{"key":"42_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/humupd\/6.6.595","volume":"6","author":"A. Fauconnier","year":"2000","unstructured":"Fauconnier A, Chapron C, Babaki-Fard K, Dubuisson J-B. Recurrence of leiomyomata after myomectomy. Hum Reprod Update. 2000;6:595\u2013602.","journal-title":"Hum Reprod Update"},{"key":"42_CR16","first-page":"1666","volume":"7","author":"A. Lethaby","year":"2002","unstructured":"Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Clin Evid. 2002;7:1666\u20131678.","journal-title":"Clin Evid"},{"key":"42_CR17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bmj.316.7138.1122","volume":"316","author":"P. L\u00e4hteenm\u00e4ki","year":"1998","unstructured":"L\u00e4hteenm\u00e4ki P, Haukkamaa M, Puolakka J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as an alternative to hysterectomy. BMJ. 1998;316:1122\u20131126.","journal-title":"BMJ"},{"key":"42_CR18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","volume":"21","author":"I.M. Spitz","year":"2009","unstructured":"Spitz IM. Clinical utility of progesterone receptor modulators and their effect on the endometrium. Curr Opin Obstet Gynecol. 2009;21:318\u2013324.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"42_CR19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","volume":"65","author":"T. Maruo","year":"2000","unstructured":"Maruo T, Matsuo H, Samoto T, et al. Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids. 2000;65:585\u2013592.","journal-title":"Steroids"},{"key":"42_CR20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijgo.2010.01.003","volume":"109","author":"T. Maruo","year":"2010","unstructured":"Maruo T. Translational research in women\u2019s health: From bedside to bench and from bench to bedside. Int J Gynecol Obstet. 2010;109:83\u201384.","journal-title":"Int J Gynecol Obstet"},{"issue":"Suppl.","key":"42_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719107311464","volume":"14","author":"N. Ohara","year":"2007","unstructured":"Ohara N, Morikawa A, Chen W, et al. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells. Reprod Sci. 2007;14(Suppl.): 20\u201327.","journal-title":"Reprod Sci."},{"key":"42_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","volume":"14","author":"Q. Xu","year":"2008","unstructured":"Xu Q, Ohara N, Liu J, et al. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells. Mol Hum Reprod. 2008;14:181\u2013191.","journal-title":"Mol Hum Reprod"},{"key":"42_CR23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","volume":"28","author":"S. Yoshida","year":"2010","unstructured":"Yoshida S, Ohara N, Xu Q, et al. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med. 2010;28:260\u2013273.","journal-title":"Semin Reprod Med"},{"key":"42_CR24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","volume":"111","author":"E.D. Levens","year":"2008","unstructured":"Levens ED, Potlog-Nahari C, Armstrong AY, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstetr Gynecol. 2008;111:1129\u20131136.","journal-title":"Obstetr Gynecol"},{"key":"42_CR25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","volume":"95","author":"L.K. Nieman","year":"2011","unstructured":"Nieman LK, Blocker W, Nansel T, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. Fertil Steril. 2011;95:767\u2013772. 1\u20132.","journal-title":"Fertil Steril."},{"key":"42_CR26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","volume":"366","author":"J. Donnez","year":"2012","unstructured":"Donnez J, Tatarchuk TF, Bouchard P, et al.; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409\u2013420.","journal-title":"N Engl J Med"},{"key":"42_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","volume":"366","author":"J. Donnez","year":"2012","unstructured":"Donnez J, Tomaszewski J, V\u00e1zquez F, et al; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366:421\u2013432.","journal-title":"N Engl J Med"},{"key":"42_CR28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humupd\/dmm023","volume":"13","author":"F.M. Horne","year":"2007","unstructured":"Horne FM, Blithe DL. Progesterone receptor modulators and the endometrium: changes and consequences. Hum Reprod Update. 2007;13:567\u2013580.","journal-title":"Hum Reprod Update"},{"key":"42_CR29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","volume":"21","author":"G.L. Mutter","year":"2008","unstructured":"Mutter GL, Bergeron C, Deligdisch L, et al. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol. 2008;21:591\u2013598.","journal-title":"Mod Pathol"},{"key":"42_CR30","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","volume":"92","author":"N. Chabbert-Buffet","year":"2007","unstructured":"Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamicpituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2007;92:3582\u20133589.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-012-0042-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-012-0042-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-012-0042-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:56:02Z","timestamp":1559462162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-012-0042-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["42"],"URL":"https:\/\/doi.org\/10.1007\/s12325-012-0042-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}